4-IMIDAZOPYRIDAZIN-1-YL-BENZAMIDES AS BTK INHIBITORS

The present invention relates to 6-5 membered fused pyridine ring compounds according to Formula (I)or a pharmaceutically acceptable salt thereof or to pharmaceutical compositions comprising these compounds and to their use in therapy. In particular, the present invention relates to the use of 6-5 m...

Full description

Saved in:
Bibliographic Details
Main Authors Barf, Tjeerd A, Jans, Christiaan Gerardus Johannes Maria, de Man, Adrianus Petrus Antonius, Wijkmans, Jacobus C.H.M, Raaijmakers, Hans C.A, Sterrenburg, Jan Gerard, Oubrie, Arthur A, Rewinkel, Johannes Bernardus Maria
Format Patent
LanguageEnglish
Published 19.10.2023
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to 6-5 membered fused pyridine ring compounds according to Formula (I)or a pharmaceutically acceptable salt thereof or to pharmaceutical compositions comprising these compounds and to their use in therapy. In particular, the present invention relates to the use of 6-5 membered fused pyridine ring compounds according to Formula (I) in the treatment of Bruton's Tyrosine Kinase (Btk) mediated disorders.
Bibliography:Application Number: US202217984242